Posts

Showing posts from July, 2018

Last Array of Hope - COVID-19 Convalescent Plasma Therapy

Image
A pilot trial of convalescent plasma treatment in 10 extreme COVID-19 patients has indicated it might be a protected and promising helpful choice. M ore than fifteen Indian states and Union Territories represent over 95% of the total coronavirus cases in the nation. Amongst them, 33% of the  cases are reported in Maharashtra and Tamil Nadu, which are speeding up lately. Economic times surveys the information, which recommends that a portion of the 15 states/UTs need to put forth a more noteworthy attempt to flatten the curve. Source: WWW.MoHFW.gov Coronavirus disease is an infectious pneumonia-related severe respiratory illness. The official name, Coronavirus disease 2019 which is also called COVID-19 was given by the world health organization (WHO), and the first case of this disease was reported in Wuhan, China.  The scourge spread quickly all around the world within 3 months and has been declared as a pandemic by WHO on March 11, 2020. As of April 13...

Several Genes- A Threat of Mental Health

Image
The origins of the violent behaviour are multifactorial and respond to the interaction of several factors -- biological, cultural, social, etc. -- which can modify the expression of the human behaviour. Which is followed by  international study published in the journal Molecular Psychiatry has identified forty genes related to aggressive behaviour in humans and mice. Aggressive behaviour is a present feature over the biological evolution since it has some benefits for the survival of species (accessing resources, breeding, etc.). As we know aggressiveness has a significant environmental element like combine genetic and environmental data from the same individuals to consider the interactions that can occur between the same risk factors that influence aggresive behavior"         According to study Humans and mice share a common genetic base regarding violent behaviour, There are some identified forty genes in humans and mice that ...

'Sound waves could provide 'liquid biopsies'

Image
Using sound waves, an international team of researchers has developed a gentle, contact-free method for separating circulating tumor cells from blood samples that is fast and efficient enough for clinical use.       Circulating tumor cells (CTCs) are small pieces of a tumor that break away and flow through the bloodstream. They contain a wealth of information about the tumor, such as its type, physical characteristics and genetic mutations.       The ability to quickly and efficiently harvest and grow these cells from a blood sample would enable "liquid biopsies" capable of providing robust diagnosis, prognosis and suggestions for treatment strategies based on individual CTC profiling.       CTCs are, however, extremely rare and difficult to catch. There are typically only a handful for every few billion blood cells running through a patient's veins. And while there are many technologies designe...

Nerve cells that help control hunger -A finding

Image
Newly identified nerve cells deep in the brains of mice compel them to eat. Similar cells exist in people, too, and may ultimately represent a new way to target eating disorders and obesity. These neurons are not the first discovered to control appetite. But because of the mysterious brain region where they are found and the potential relevance to people, the mouse results “are worth pursuing,” says neurobiologist and physiologist Sabrina Diano of Yale University School of Medicine. Certain nerve cells in the human brain region called the nucleus tuberalis lateralis, or NTL, are known to malfunction in neurodegenerative diseases such as Huntington’s and Alzheimer’s. But “almost nothing is known about [the region],” says study coauthor Yu Fu of the Singapore Bioimaging Consortium, Agency for Science, Technology and Research. In people, the NTL is a small bump along the bottom edge of the hypothalamus, a brain structure known to regulate eating behavior. But in mice,...

Type 2 diabetes: Progressing novel scientific insight into new medicine

Image
The gap in the long process of progressing a novel scientific insight into a new medicine is often called “the valley of death”. Read below to understand how the strategic alliance between University of Oxford and Novo Nordisk is aiming to combat type 2 diabetes by bridging this gap The gap between translating basic research discoveries into medicines is often called “the valley of death”. The process of progressing a novel scientific insight into a new medicine is long, challenging, labour-intensive and expensive and all too often exciting ideas are lost along the way. The strategic alliance between the University of Oxford and Novo Nordisk aims to bridge that gap, by marrying leading academic science with the best of pharmaceutical research and development capabilities. Fuelled by an obesity pandemic, type 2 diabetes affects more than 379 million people1 and is today the fastest-growing chronic disease on a global level2. It is this challenge that research in the al...